Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Table 1 shows the percentages of activated CD4 and CD8 T-cell subsets in LTNP,
asymptomatic progressors and uninfected controls at the baseline study. In comparison with …

Early events during primary HIV infection (PHI) are thought to influence disease outcome.
Although a growing body of evidence suggests a beneficial role of HIV-specific CD4 help in …

During the 1990s, high prevalences of HIV/human T lymphotropic virus type 1 (HTLV-1) and
HIV/human T lymphotropic virus type 2 (HTLV-2) coinfections were detected in São Paulo …

The Human T lymphotropic virus type-1 (HTLV-1) infects predominantly T cells, inducing
proliferation and lymphocyte activation. Additionally, HTLV-1 infected subjects are more …

ABSTRACT A recent theory stipulates that during the course of HIV infection, there is a shift
in immune response from T-helper 1 to T-helper 2 responses, characterised by elevated …

Human immunodeficiency virus (HIV)–specific CD4+ and CD8+ T cell responses were
evaluated prospectively in a large cohort of subjects with HIV primary infection via long-term …

Serum samples from 895 HIV-1 infected individuals were tested for antibodies against HTLV-
I and HTLV-II. The overall prevalence of the co-infection was high (16.3%). Epidemiological …

Background: The concept of HIV-1/HSV-negative immunosynergy has recently come to light,
which leads us to explore the impact of HIV-1 infection on HSV-specific T-cell immunity …

The prevalence and the risk factors of the human T-cell leukemia virus type I/II (HTLV-I/II)
infection were evaluated among 552 individuals at high risk for HIV-1. HTLV infections …